Statistics from Altmetric.com
Treatment of venous thromboembolism has evolved considerably over the last twenty years. The use of subcutaneous low molecular weight heparin without a requirement for monitoring has lessened the burden of treatment and opened the door for outpatient therapy.1 This is a well-accepted practise for patients with deep vein thrombosis (DVT), but concern has remained for similar treatment of pulmonary embolism.
Some of the reluctance to treat as an outpatient is emotional, given that many patients with DVT already have an asymptomatic pulmonary embolism.2 There clearly is legitimate concern as well, given the high risk of complications with pulmonary embolism, including higher death and in some studies, higher risk of recurrence.3 Our group and others in Canada and Europe have been treating patients with a pulmonary embolism on an outpatient basis using loosely defined criteria: eligible patients must have no hypoxia, hypotension, no need for …
Competing interests None.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.